Neurons Use SPP1 to Command Microglia Into Protective Mode During Degeneration
A neuron-secreted protein reprograms brain immune cells to clear debris and protect neighbors, revealing a conserved defense axis in glaucoma and Alzheimer's.
Summary
Researchers at Harvard discovered that alpha retinal ganglion cells (αRGCs) secrete SPP1 (osteopontin) after injury, signaling microglia to adopt a neuroprotective state. In mouse glaucoma and optic nerve crush models, neuronal SPP1 enhanced microglial autophagy, debris clearance, and anti-inflammatory activity, preserving both SPP1-expressing and neighboring neurons. Conditional deletion of Spp1 specifically in αRGCs worsened loss of all ganglion cell types and impaired visual function. SPP1 acts via microglial integrin αV receptors. The findings extend to human and primate glaucomatous retinas, Alzheimer's disease brain tissue, and human iPSC-derived neuron–microglia co-cultures, suggesting SPP1 defines a conserved neuron–microglia protective axis across neurodegenerative conditions.
Detailed Summary
Neurons are not passive bystanders during neuroinflammation — they actively shape microglial behavior. This study identifies SPP1 (secreted phosphoprotein 1, also called osteopontin) as a neuron-derived immunomodulatory signal that reprograms microglia toward a neuroprotective, homeostatic phenotype following injury and during neurodegeneration.
Using mouse models of glaucoma (elevated intraocular pressure) and traumatic optic nerve crush, the authors showed that SPP1 is constitutively expressed in large alpha retinal ganglion cells (αRGCs) and is markedly upregulated after injury, spreading from the perinuclear region throughout the soma, axon, and dendrites. This upregulation is driven by TGF-β1 signaling through the transcription factors RUNX1 and E2F1. Critically, injury did not induce SPP1 in non-alpha RGCs, Müller cells, astrocytes, or retinal microglia, confirming αRGCs as the dominant neuronal source.
Conditional deletion of Spp1 specifically in αRGCs (Spp1 cKO) worsened degeneration not only in SPP1-expressing αRGCs but also in SPP1-negative neighboring ganglion cells, indicating a non-cell-autonomous protective mechanism. Pattern electroretinography and visual acuity were more severely impaired in Spp1 cKO mice after IOP elevation. Mechanistically, SPP1 acts on microglial integrin αV (ItgαV) receptors. Loss of ItgαV in microglia phenocopied Spp1 deletion, causing exaggerated microglial activation (enlarged soma, retracted processes, amoeboid morphology) and worsened neuronal loss. Conversely, SPP1 supplementation suppressed microglial reactivity, enhanced autophagy and lysosomal activity, promoted debris clearance, and stimulated anti-inflammatory IL-10 production.
The translational relevance is substantial. In human and nonhuman primate glaucomatous retinas, SPP1-positive neurons showed increased resilience compared to SPP1-negative counterparts. In Alzheimer's disease brain sections, neuronal SPP1 levels correlated with neuronal survival, while microglia surrounding amyloid-beta (Aβ) plaques displayed impaired autophagy. In human iPSC-derived neuron–microglia co-cultures, exogenous SPP1 enhanced microglial Aβ clearance and reduced neurodegeneration, directly linking the mouse mechanistic findings to a human disease-relevant system.
Together, these findings define a conserved neuroimmune protective axis: stressed neurons secrete SPP1 to instruct microglia to clear debris and suppress harmful inflammation, thereby protecting the broader neuronal population. This positions neuronal SPP1 as a master regulator of microglial phenotype during neurodegeneration and a compelling therapeutic target.
Key Findings
- αRGC-derived SPP1 is upregulated after glaucomatous or traumatic injury via TGF-β1/RUNX1/E2F1 signaling.
- Conditional Spp1 deletion in αRGCs worsened loss of all RGC subtypes and impaired visual function.
- SPP1 acts via microglial integrin αV to suppress activation, boost autophagy, and promote IL-10 secretion.
- SPP1-positive neurons show greater resilience in human/primate glaucoma and Alzheimer's disease brain tissue.
- In iPSC-derived co-cultures, SPP1 enhanced microglial Aβ clearance and prevented neurodegeneration.
Methodology
The study combined mouse genetic models (global Spp1 KO and αRGC-specific Spp1 cKO using Kcng4-Cre) with glaucoma (IOP elevation) and optic nerve crush paradigms, supplemented by integrin αV conditional microglial knockouts. Translational validation used human and nonhuman primate glaucomatous retinas, Alzheimer's disease postmortem brain sections, and human iPSC-derived neuron–microglia co-cultures with Aβ challenge.
Study Limitations
The full paper excerpt is partially truncated, limiting assessment of all experimental controls. The iPSC co-culture system, while human-derived, may not fully recapitulate the complexity of in vivo human brain microenvironments. Causal directionality in human Alzheimer's tissue is correlational, not established by intervention.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: